China's COVID scare sparks run on flu medicines, test kits as far away
as Australia
Send a link to a friend
[December 15, 2022]
By Stella Qiu and Sophie Yu
SYDNEY/BEIJING (Reuters) - The rising alarm over COVID-19 spreading in
China was felt in pharmacies in Hong Kong, Macau, and in some
neighbourhoods in Australia, as people hunted for fever medicines and
virus test kits to send to family and friends on the mainland.
China's sudden easing of strict COVID rules last week triggered a surge
in demand for these items on the mainland, with queues forming outside
pharmacies and online platforms quickly selling out.
Several shops have since imposed limits on how much customers can buy,
and drugmakers are ramping up production.
"Chinese people like to hoard things. How could there be anything left?
They like to hoard medicines before they even get sick," said a doctor
in Shanghai.
Chang Linyun, a 42-year-old mother in Beijing, said she tried to ask
friends in Australia to buy fever medicine for her young son, as the
drugstores were sold out, and traders who use social media and mobile
apps to source and provide goods to customers, known as "daigou", were
charging too much.
"I'd like to buy two bottles of Panadol and two bottles of Nurofen...
(But) my friend told me that drug stores near her home in Melbourne have
all sold out of fever medicine, because too many Chinese daigou are
buying," Chang said.
In Box Hill, a suburb of Melbourne and home to one of Australia's
largest Chinese communities, a pharmacist said several drugstores had
run out of Panadol.
In Hong Kong, two sales staff in a pharmacy shop said there were very
low stocks of Panadol across its network in the city, even as its Health
Secretary Lo Chung-mau said on Sunday that the government will ensure
the supply of paracetamol-based drugs to calm fears of a shortage.
[to top of second column]
|
People stand in a queue to purchase
medicines at a pharmacy in Beijing, China December 14, 2022, in this
screen grab taken from a Reuters TV video. REUTERS TV via
REUTERS/File Photo
"I have friends in Beijing who asked
me to send over some flu medicines and rapid tests. They just
couldn't get any in Beijing, they placed orders online, but nothing
gets sent," said a 30-year-old woman in Hong Kong surnamed Lo who
was buying flu and anti-fever medicines and COVID tests to send to
her friends.
In Macau, health authorities have imposed purchase limits for
antiviral drugs used to treat COVID-19 symptoms.
Xiangxue Pharmaceutical, which produces an antiviral solution, said
on Monday it was "going all out" to increase output in response to a
question on the shortages in pharmacies.
And the government-backed Sinopharm Group has tripled daily
production capacity of key drugs, state run CCTV reported, due to a
sharp increase in demand for medicines to treat fever and cough
symptoms.
(Reporting by Stella Qiu in Sydney, Farah Master, Selena Li and
Julie Zhu in Hong Kong, Sonali Paul in Melbourne, Xinghui Kok in
Singapore, Sophie Yu in Beijing, Brenda Goh in Shanghai; Writing by
Miyoung Kim; Editing by Simon Cameron-Moore)
[© 2022 Thomson Reuters. All rights
reserved.] This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|